Cargando…

1026. Following the Hoof Prints: Detecting Coxiella and Brucella infections with A Plasma-based Microbial Cell-Free DNA Next-generation Sequencing Test

BACKGROUND: Coxiella burnetii and Brucella spp. are zoonotic bacterial pathogens responsible for Q fever and Brucellosis, respectively. Both pathogens have a global distribution and Brucellosis is the most common zoonosis in the world. However, the CDC reports only 80-120 cases of human brucellosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Degner, Nicholas R, Castillo-Galvan, Ricardo, Alexander, Jose, Arun, Aparna, de Vries, Christiaan R, Macintyre, Ann, Perkins, Bradley, Ahmed, Asim A, Smollin, Matthew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644969/
http://dx.doi.org/10.1093/ofid/ofab466.1220
_version_ 1784610209831845888
author Degner, Nicholas R
Castillo-Galvan, Ricardo
Alexander, Jose
Arun, Aparna
de Vries, Christiaan R
Macintyre, Ann
Perkins, Bradley
Ahmed, Asim A
Smollin, Matthew
author_facet Degner, Nicholas R
Castillo-Galvan, Ricardo
Alexander, Jose
Arun, Aparna
de Vries, Christiaan R
Macintyre, Ann
Perkins, Bradley
Ahmed, Asim A
Smollin, Matthew
author_sort Degner, Nicholas R
collection PubMed
description BACKGROUND: Coxiella burnetii and Brucella spp. are zoonotic bacterial pathogens responsible for Q fever and Brucellosis, respectively. Both pathogens have a global distribution and Brucellosis is the most common zoonosis in the world. However, the CDC reports only 80-120 cases of human brucellosis and ~150 cases of acute Q fever annually. The diagnosis of these infections can be limited by: (1) their difficulty to culture; (2) the insensitivity and nonspecificity of serology; (3) the clinical overlap with other infections; and (4) the unreliability of epidemiological exposure history for these zoonoses. Unbiased microbial cell free DNA (mcfDNA) next-generation sequencing (NGS) offers a potential solution to overcome these limitations. METHODS: The Karius Test(TM) (KT) developed and validated in Karius’s CLIA certified/CAP accredited lab in Redwood City, CA detects mcfDNA in plasma. After mcfDNA is extracted and NGS performed, human reads are removed, and remaining sequences are aligned to a curated database of > 1500 organisms. McfDNA from organisms present above a statistical threshold are reported and quantified in molecules/µL (MPM). KT detections of Coxiella and Brucella were reviewed from August 2017 - present; clinical information was obtained with test requisition or consultation upon result reporting. RESULTS: KT detected 8 cases of Coxiella burnetii (1735 MPM +/- 3000) and 5 cases of Brucella melitensis (avg 296 MPM +/- 223) (Table 1), representing approximately 1-2% of all detections in the US during this period. All of the Coxiella detections were in adults (100% male) with 5 cases of fever of unknown origin, 2 cases of culture-negative endocarditis and one case of endovascular graft infection. Brucella detections occurred in 3 adults and 2 children (60% male), 3 with exposure to unpasteurized dairy and included 3 cases of spine infection (2 vertebral osteomyelitis, 1 epidural abscess). [Image: see text] CONCLUSION: Open-ended, plasma-based mcfDNA NGS provides a rapid, non-invasive test to diagnose diverse clinical manifestations of zoonotic infections such as Q fever and Brucellosis against competing broad differential diagnoses. Furthermore, these cases highlight the potential of the KT to diagnose infections caused by fastidious/unculturable pathogens with cryptic clinical presentations. DISCLOSURES: Nicholas R. Degner, MD, MPH, MS, Karius Inc. (Employee, Shareholder) Ricardo Castillo-Galvan, MD MPH, Karius Inc. (Consultant) Jose Alexander, MD, D(ABMM), FCCM, CIC, SM, MB(ASCP), BCMAS, Karius (Employee) Aparna Arun, MD, Karius (Employee) Ann Macintyre, DO, Karius, Inc. (Employee) Bradley Perkins, MD, Karius, Inc. (Employee) Asim A. Ahmed, MD, Karius, Inc. (Employee) Matthew Smollin, PharmD, Karius, Inc. (Employee)
format Online
Article
Text
id pubmed-8644969
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-86449692021-12-06 1026. Following the Hoof Prints: Detecting Coxiella and Brucella infections with A Plasma-based Microbial Cell-Free DNA Next-generation Sequencing Test Degner, Nicholas R Castillo-Galvan, Ricardo Alexander, Jose Arun, Aparna de Vries, Christiaan R Macintyre, Ann Perkins, Bradley Ahmed, Asim A Smollin, Matthew Open Forum Infect Dis Poster Abstracts BACKGROUND: Coxiella burnetii and Brucella spp. are zoonotic bacterial pathogens responsible for Q fever and Brucellosis, respectively. Both pathogens have a global distribution and Brucellosis is the most common zoonosis in the world. However, the CDC reports only 80-120 cases of human brucellosis and ~150 cases of acute Q fever annually. The diagnosis of these infections can be limited by: (1) their difficulty to culture; (2) the insensitivity and nonspecificity of serology; (3) the clinical overlap with other infections; and (4) the unreliability of epidemiological exposure history for these zoonoses. Unbiased microbial cell free DNA (mcfDNA) next-generation sequencing (NGS) offers a potential solution to overcome these limitations. METHODS: The Karius Test(TM) (KT) developed and validated in Karius’s CLIA certified/CAP accredited lab in Redwood City, CA detects mcfDNA in plasma. After mcfDNA is extracted and NGS performed, human reads are removed, and remaining sequences are aligned to a curated database of > 1500 organisms. McfDNA from organisms present above a statistical threshold are reported and quantified in molecules/µL (MPM). KT detections of Coxiella and Brucella were reviewed from August 2017 - present; clinical information was obtained with test requisition or consultation upon result reporting. RESULTS: KT detected 8 cases of Coxiella burnetii (1735 MPM +/- 3000) and 5 cases of Brucella melitensis (avg 296 MPM +/- 223) (Table 1), representing approximately 1-2% of all detections in the US during this period. All of the Coxiella detections were in adults (100% male) with 5 cases of fever of unknown origin, 2 cases of culture-negative endocarditis and one case of endovascular graft infection. Brucella detections occurred in 3 adults and 2 children (60% male), 3 with exposure to unpasteurized dairy and included 3 cases of spine infection (2 vertebral osteomyelitis, 1 epidural abscess). [Image: see text] CONCLUSION: Open-ended, plasma-based mcfDNA NGS provides a rapid, non-invasive test to diagnose diverse clinical manifestations of zoonotic infections such as Q fever and Brucellosis against competing broad differential diagnoses. Furthermore, these cases highlight the potential of the KT to diagnose infections caused by fastidious/unculturable pathogens with cryptic clinical presentations. DISCLOSURES: Nicholas R. Degner, MD, MPH, MS, Karius Inc. (Employee, Shareholder) Ricardo Castillo-Galvan, MD MPH, Karius Inc. (Consultant) Jose Alexander, MD, D(ABMM), FCCM, CIC, SM, MB(ASCP), BCMAS, Karius (Employee) Aparna Arun, MD, Karius (Employee) Ann Macintyre, DO, Karius, Inc. (Employee) Bradley Perkins, MD, Karius, Inc. (Employee) Asim A. Ahmed, MD, Karius, Inc. (Employee) Matthew Smollin, PharmD, Karius, Inc. (Employee) Oxford University Press 2021-12-04 /pmc/articles/PMC8644969/ http://dx.doi.org/10.1093/ofid/ofab466.1220 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Abstracts
Degner, Nicholas R
Castillo-Galvan, Ricardo
Alexander, Jose
Arun, Aparna
de Vries, Christiaan R
Macintyre, Ann
Perkins, Bradley
Ahmed, Asim A
Smollin, Matthew
1026. Following the Hoof Prints: Detecting Coxiella and Brucella infections with A Plasma-based Microbial Cell-Free DNA Next-generation Sequencing Test
title 1026. Following the Hoof Prints: Detecting Coxiella and Brucella infections with A Plasma-based Microbial Cell-Free DNA Next-generation Sequencing Test
title_full 1026. Following the Hoof Prints: Detecting Coxiella and Brucella infections with A Plasma-based Microbial Cell-Free DNA Next-generation Sequencing Test
title_fullStr 1026. Following the Hoof Prints: Detecting Coxiella and Brucella infections with A Plasma-based Microbial Cell-Free DNA Next-generation Sequencing Test
title_full_unstemmed 1026. Following the Hoof Prints: Detecting Coxiella and Brucella infections with A Plasma-based Microbial Cell-Free DNA Next-generation Sequencing Test
title_short 1026. Following the Hoof Prints: Detecting Coxiella and Brucella infections with A Plasma-based Microbial Cell-Free DNA Next-generation Sequencing Test
title_sort 1026. following the hoof prints: detecting coxiella and brucella infections with a plasma-based microbial cell-free dna next-generation sequencing test
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644969/
http://dx.doi.org/10.1093/ofid/ofab466.1220
work_keys_str_mv AT degnernicholasr 1026followingthehoofprintsdetectingcoxiellaandbrucellainfectionswithaplasmabasedmicrobialcellfreednanextgenerationsequencingtest
AT castillogalvanricardo 1026followingthehoofprintsdetectingcoxiellaandbrucellainfectionswithaplasmabasedmicrobialcellfreednanextgenerationsequencingtest
AT alexanderjose 1026followingthehoofprintsdetectingcoxiellaandbrucellainfectionswithaplasmabasedmicrobialcellfreednanextgenerationsequencingtest
AT arunaparna 1026followingthehoofprintsdetectingcoxiellaandbrucellainfectionswithaplasmabasedmicrobialcellfreednanextgenerationsequencingtest
AT devrieschristiaanr 1026followingthehoofprintsdetectingcoxiellaandbrucellainfectionswithaplasmabasedmicrobialcellfreednanextgenerationsequencingtest
AT macintyreann 1026followingthehoofprintsdetectingcoxiellaandbrucellainfectionswithaplasmabasedmicrobialcellfreednanextgenerationsequencingtest
AT perkinsbradley 1026followingthehoofprintsdetectingcoxiellaandbrucellainfectionswithaplasmabasedmicrobialcellfreednanextgenerationsequencingtest
AT ahmedasima 1026followingthehoofprintsdetectingcoxiellaandbrucellainfectionswithaplasmabasedmicrobialcellfreednanextgenerationsequencingtest
AT smollinmatthew 1026followingthehoofprintsdetectingcoxiellaandbrucellainfectionswithaplasmabasedmicrobialcellfreednanextgenerationsequencingtest